Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Micropos Medical

1.27 SEK+8.09 %20.11, 17.29
Less than 1K followers

MPOS

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+8.09 %
+50.83 %
+6.28 %
+7.63 %
+2.83 %
-23.49 %
-39.95 %
-63.27 %
-79.03 %

Micropos Medical operates in medical technology. The company's products are used in radiotherapy. The vision is to develop a technology that will pinpoint diseases during said treatment, where product development is based on an electromagnetic positioning system. The product creates real-time information and is used primarily for the treatment of prostate cancer, but also for other tumor treatments. The company was established in 2003 and has its headquarters in Gothenburg.

Read more
Market cap
234.95M SEK
Turnover
184.76K SEK
Revenue
8.13M
EBIT %
-265.81 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
29.1
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release04.11.2026, 09.30

Micropos Medical: Cooperation for greater awareness of high precision radiotherapy for prostate cancer

Micropos Medical
Regulatory press release25.09.2026, 11.50

Micropos Medical: Hospital Meixoeiro do Vigo in Spain Treats Its First Patient with the Raypilot® System

Micropos Medical
Regulatory press release23.09.2026, 11.30

Swedes Treated for Prostate Cancer in Italy - A Method Associated with Fewer Side Effects

Micropos Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release01.07.2026, 12.00

Micropos Medical Announces Initial Clinical Treatments at Johns Hopkins Medicine Using Raypilot System

Micropos Medical
Press release10.03.2026, 08.00

Micropos Medical: First Multi Functional European Training in Augmented SBRT conducted in Monza

Micropos Medical
Press release29.01.2026, 16.00

Micropos Medical: Velindre Cancer Center Enters Agreement for the Implementation of the Raypilot System

Micropos Medical
Press release28.01.2026, 11.00

Micropos Medical: St Luke's Hospital in Dublin starts ASBRT Treatments Using Raypilot System

Micropos Medical